Literature DB >> 16482642

Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis.

Dana Jacobs-Kosmin1, Chris T Derk, Nora Sandorfi.   

Abstract

Systemic vasculitis may, at times, be drug-induced and associated with antineutrophil cytoplasmic antibodies (ANCA). However, pantoprazole, a commonly used and well-tolerated proton pump inhibitor, has not previously been reported to cause ANCA-associated syndromes. We describe a patient who developed interstitial nephritis, cutaneous vasculitis, a perinuclear ANCA staining pattern (pANCA) on immunofluorescence, and anti-myeloperoxidase antibodies (MPO-ANCA) in association with pantoprazole. We review various immune-mediated syndromes reported in association with proton pump inhibitors, including one report of omeprazole associated with interstitial nephritis and the development of ANCA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482642

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  1 in total

1.  Drug rash with eosinophilia and systemic symptoms and severe renal injury induced by proton pump inhibitor therapy: A case report.

Authors:  Qien He; Guanghui Ying; Xiapei Fei; Chenqin Zha; Zhaogui Chen; Yishu Bao; Jiaorong Long; Zhujun Wang; Xuelin He; Min Xia
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.